Bank of New York Mellon Corp Sells 156,716 Shares of HCA Healthcare, Inc. $HCA

Bank of New York Mellon Corp lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 13.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 969,967 shares of the company’s stock after selling 156,716 shares during the quarter. Bank of New York Mellon Corp’s holdings in HCA Healthcare were worth $452,839,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nordea Investment Management AB increased its holdings in HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares during the period. Savant Capital LLC increased its holdings in HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares during the period. Hudson Bay Capital Management LP increased its holdings in HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after acquiring an additional 2,849 shares during the period. Advisors Capital Management LLC increased its holdings in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC increased its holdings in shares of HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after buying an additional 8,733 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.9%

Shares of HCA Healthcare stock opened at $364.00 on Thursday. The firm has a market cap of $80.75 billion, a PE ratio of 12.52, a price-to-earnings-growth ratio of 1.16 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The company’s fifty day simple moving average is $444.21 and its two-hundred day simple moving average is $478.72.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. During the same period last year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analysts Set New Price Targets

A number of brokerages have recently commented on HCA. Robert W. Baird decreased their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Sanford C. Bernstein decreased their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. UBS Group increased their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.